(Q34807496)

4 August 2017

1 reference

title

Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development (English)

1 reference

Socio-economic consequences

4 August 2017

0 references

0 references

0 references

0 references

author

Philippe J. Guerin

series ordinal

1

1 reference

4 August 2017

3

1 reference

4 August 2017

9

Nicholas J White

1 reference

4 August 2017

2

Piero Olliaro

1 reference

4 August 2017

4

Pierre Druilhe

1 reference

4 August 2017

5

Ramanan Laxminarayan

1 reference

4 August 2017

8

Nathan Ford

1 reference

4 August 2017

Fred Binka

6

1 reference

4 August 2017

Wen L Kilama

series ordinal

7

1 reference

4 August 2017

Guerin, P.J.

0 references

Olliaro, P.

0 references

Nosten, F.

0 references

Druilhe, P.

0 references

Laxminarayan, R.

0 references

Binka, F.

0 references

Kilama, W.L.

0 references

Ford, N.

0 references

White, N.J.

0 references

publication date

1 September 2002

1 reference

Lancet Infectious Diseases

4 August 2017

2002

0 references

published in

1 reference

4 August 2017

2

1 reference

4 August 2017

564-573

1 reference

4 August 2017

9

1 reference

http://ugspace.ug.edu.gh/handle/123456789/28445

4 August 2017

0 references

cites work

The economic and social burden of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Malaria, the submerged disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Malaria disaster in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The malaria burden and the need for research and capacity strengthening in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Impact of chloroquine resistance on malaria mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The economic burden of malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Impact of Plasmodium falciparum malaria on performance and learning: review of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The intolerable burden of malaria: a new look at the numbers.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The burden of malaria in pregnancy in malaria-endemic areas.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The Gambian national impregnated bednet programme: Costs, consequences and net cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Efficacy and cost-effectiveness of environmental management for malaria control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Insecticide-treated materials for malaria control in Latin America: to use or not to use?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Progress and challenges for malaria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Clinical trials of malaria vaccines: progress and prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Malaria transmission-blocking vaccines--how can their development be supported?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

An efficacy trial of the malaria vaccine SPf66 in Gambian infants--second year of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Malaria vaccines: are seven antigens better than one?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Risk factors for anemia in young children in rural Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Fever in Africa: do patients know when they are hot?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The epidemiology of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Presumptive diagnosis of malaria results in a significant risk of mistreatment of children in urban Sahel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Clinical algorithm for treatment of Plasmodium falciparum malaria in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Malaria diagnosis and treatment under the strategy of the integrated management of childhood illness (IMCI): relevance of laboratory support from the rapid immunochromatographic tests of ICT Malaria P.f/P.v and OptiMal

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The diagnosis of Plasmodium falciparum infection in Gambian children, by field staff using the rapid, manual, ParaSight-F test

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Comparison of a parasite lactate dehydrogenase-based immunochromatographic antigen detection assay (OptiMAL) with microscopy for the detection of malaria parasites in human blood samples.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Paracheck-Pf: a new, inexpensive and reliable rapid test for P. falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

MalaQuick versus ParaSight F as a diagnostic aid in travellers' malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Non-microscopic methods for diagnosis of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Cost-effectiveness of malaria control in sub-Saharan Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Uganda leads the way on Africa Malaria Day.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Making malaria-treatment policy in the face of drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Modelling a predictable disaster: the rise and spread of drug-resistantmalaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Antimalarial drug resistance and combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Fake antimalaria drugs in Cambodia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Fake artesunate in southeast Asia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Antimalarial drug resistance and mortality in falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Mode of action and mechanisms of resistance for antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Modern chemotherapeutic options for malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Combination therapy for malaria: the way forward?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Averting a malaria disaster

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Dexamethasone deleterious in cerebral malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

An assessment of low birthweight risk in primiparae as an indicator of malaria control in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Malaria and pregnancy: epidemiology, pathophysiology and control options

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Artemisinin derivatives in the treatment of falciparum malaria in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The neglected burden of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Drug resistant falciparum malaria: clinical consequences and strategies for prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

DNA microarrays for malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The impact of whole genome sequence data on drug discovery--a malaria case study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

1 reference

7 January 2021

Malaria: new developments in treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Drug development output from 1975 to 1996: what proportion for tropical diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

Drug development for neglected diseases: a deficient market and a public-health policy failure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

The HIV/AIDS pandemic: a sign of instability in a complex global system.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900372-9

7 January 2021

10.1016/S1473-3099(02)00372-9

Identifiers

DOI

1 reference

release_suumkhekznaptjzlbrf2al2may

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/suumkhekznaptjzlbrf2al2may

24 November 2022

mapped directly with Wikidata item

1 reference